3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1194

Change

-29.50 (-2.41)%

Market Cap

N/A

Volume

165.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.01 (-1.92%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

+0.03 (+0.31%)

N/A
0240-OL:HK BUILD KING HOLD

+0.05 (+4.59%)

N/A
0243-OL:HK QPL INT'L

N/A

N/A
0182-OL:HK CHINA WINDPOWER

+0.01 (+1.11%)

N/A
0259-OL:HK YEEBO (INT'L H)

-0.03 (-1.84%)

N/A
0187-OL:HK JINGCHENG MAC

+0.21 (+5.38%)

N/A

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 10.22 % 0.43 %

+1.26 (+1.45%)

N/A
TETF 6.19 % 0.64 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.16 % 0.00 %

N/A

CAD 0.05B
MID American Century Mid Cap .. 4.56 % 0.00 %

+1.50 (+1.45%)

USD 0.07B
IAI iShares U.S. Broker-Deale.. 4.54 % 0.42 %

+4.50 (+1.45%)

N/A
LCG Sterling Capital Focus Eq.. 4.46 % 0.00 %

+0.73 (+1.45%)

USD 0.03B
LONG:CA CI Global Longevity Econo.. 4.01 % 0.00 %

+0.24 (+1.45%)

CAD 3.81M
CBUF:XETRA iShares MSCI World Health.. 3.37 % 0.00 %

-0.05 (1.45%)

N/A
PSL Invesco DWA Consumer Stap.. 3.25 % 0.60 %

+2.23 (+1.45%)

USD 0.09B
CBLS Elevation Series Trust 3.19 % 0.00 %

+0.32 (+1.45%)

USD 0.04B
CBSE Elevation Series Trust 2.98 % 0.00 %

+0.76 (+1.45%)

USD 0.02B
HDIV 2.83 % 0.00 %

N/A

N/A
FXH First Trust Health Care A.. 2.31 % 0.63 %

+2.26 (+1.45%)

USD 0.89B
TDOC:CA TD Global Healthcare Lead.. 2.25 % 0.00 %

+0.25 (+1.45%)

CAD 0.08B
FLXG:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

N/A
FRGE:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

USD 0.02B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
CVY Invesco Zacks Multi-Asset.. 1.18 % 0.65 %

+0.56 (+1.45%)

USD 0.10B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.04 (1.45%)

USD 0.08B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
RYF 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+1.05 (+1.45%)

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

+0.60 (+1.45%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

-3.88 (1.45%)

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.05 (+1.45%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.10 (1.45%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.03 (1.45%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.03 (1.45%)

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+1.96 (+1.45%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.14% 31% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.14% 31% F 32% F
Trailing 12 Months  
Capital Gain 3.38% 51% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.38% 49% F 51% F
Trailing 5 Years  
Capital Gain 102.72% 84% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 102.72% 84% B 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.78% 77% C+ 75% C
Dividend Return 15.78% 75% C 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.77% 79% B- 78% C+
Risk Adjusted Return 84.08% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike